Several studies have shown that patients with stable COPD and CVD have higher levels of systemic inflammatory biomarkers, such as fibrinogen, C-reactive protein (CRP), interleukin (IL)-6, and IL-8 [25,26]. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.